Cite
16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction.
MLA
Thrane, Pernille G., et al. “16-Year Follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) Trial: Primary Percutaneous Coronary Intervention vs. Fibrinolysis in ST-Segment Elevation Myocardial Infarction.” European Heart Journal, vol. 41, no. 7, Feb. 2020, pp. 847–54. EBSCOhost, https://doi.org/10.1093/eurheartj/ehz595.
APA
Thrane, P. G., Kristensen, S. D., Olesen, K. K. W., Mortensen, L. S., Bøtker, H. E., Thuesen, L., Hansen, H. S., Abildgaard, U., Engstrøm, T., Andersen, H. R., & Maeng, M. (2020). 16-year follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) trial: primary percutaneous coronary intervention vs. fibrinolysis in ST-segment elevation myocardial infarction. European Heart Journal, 41(7), 847–854. https://doi.org/10.1093/eurheartj/ehz595
Chicago
Thrane, Pernille G, Steen D Kristensen, Kevin K W Olesen, Leif S Mortensen, Hans Erik Bøtker, Leif Thuesen, Henrik S Hansen, et al. 2020. “16-Year Follow-up of the Danish Acute Myocardial Infarction 2 (DANAMI-2) Trial: Primary Percutaneous Coronary Intervention vs. Fibrinolysis in ST-Segment Elevation Myocardial Infarction.” European Heart Journal 41 (7): 847–54. doi:10.1093/eurheartj/ehz595.